Alps Advisors Inc. lessened its stake in Waters Corporation (NYSE:WAT) by 19.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,476 shares of the medical instruments supplier’s stock after selling 586 shares during the quarter. Alps Advisors Inc.’s holdings in Waters were worth $444,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. OppenheimerFunds Inc. grew its position in shares of Waters by 2.0% during the 1st quarter. OppenheimerFunds Inc. now owns 1,750 shares of the medical instruments supplier’s stock worth $274,000 after buying an additional 35 shares during the period. Dimensional Fund Advisors LP boosted its stake in Waters by 1.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 207,633 shares of the medical instruments supplier’s stock worth $32,455,000 after acquiring an additional 3,187 shares during the last quarter. Louisiana State Employees Retirement System boosted its stake in Waters by 2.0% during the 2nd quarter. Louisiana State Employees Retirement System now owns 5,000 shares of the medical instruments supplier’s stock worth $919,000 after acquiring an additional 100 shares during the last quarter. US Bancorp DE boosted its stake in Waters by 1.1% during the 2nd quarter. US Bancorp DE now owns 15,569 shares of the medical instruments supplier’s stock worth $2,862,000 after acquiring an additional 166 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC bought a new position in Waters during the 2nd quarter worth approximately $279,000. Hedge funds and other institutional investors own 92.29% of the company’s stock.
In other news, Director Thomas P. Salice sold 3,500 shares of the stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $200.03, for a total value of $700,105.00. Following the completion of the transaction, the director now owns 20,349 shares of the company’s stock, valued at $4,070,410.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Rohit Khanna sold 26,913 shares of the company’s stock in a transaction that occurred on Friday, October 27th. The shares were sold at an average price of $197.93, for a total value of $5,326,890.09. Following the completion of the transaction, the senior vice president now directly owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The disclosure for this sale can be found here. Insiders have sold 64,313 shares of company stock valued at $12,503,037 in the last ninety days. 5.07% of the stock is currently owned by company insiders.
Shares of Waters Corporation (NYSE:WAT) traded up $1.27 during trading on Thursday, hitting $196.47. 388,158 shares of the stock were exchanged, compared to its average volume of 514,504. The company has a market capitalization of $15,450.08, a PE ratio of 26.98, a PEG ratio of 2.82 and a beta of 0.82. Waters Corporation has a 52 week low of $133.71 and a 52 week high of $201.95. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16.
Waters (NYSE:WAT) last announced its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.03. Waters had a net margin of 24.34% and a return on equity of 23.61%. The company had revenue of $565.58 million during the quarter, compared to analysts’ expectations of $555.25 million. During the same quarter in the previous year, the business posted $1.57 earnings per share. Waters’s quarterly revenue was up 7.4% on a year-over-year basis. equities analysts anticipate that Waters Corporation will post 7.42 EPS for the current year.
WAT has been the topic of a number of research reports. BidaskClub raised shares of Waters from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, August 16th. Jefferies Group reaffirmed a “hold” rating and issued a $175.00 price target on shares of Waters in a research note on Thursday, August 31st. Goldman Sachs Group assumed coverage on shares of Waters in a research report on Tuesday, September 26th. They issued a “hold” rating and a $180.00 price objective on the stock. Morgan Stanley reissued an “underweight” rating and issued a $192.00 price objective (up previously from $183.00) on shares of Waters in a research report on Friday, October 6th. Finally, Cleveland Research lowered shares of Waters from a “buy” rating to a “neutral” rating in a research report on Monday, October 9th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Waters currently has an average rating of “Hold” and an average target price of $193.62.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/07/alps-advisors-inc-has-444000-holdings-in-waters-corporation-wat.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.